RetinalGenix Technologies Inc. (RTGN)
About RetinalGenix Technologies Inc.
RETINALGENIX TECHNOLOGIES
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$2.4M
- Total assets
- $21.0K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
RetinalGenix Technologies Inc. (RTGN) Stock Price
- Reported a net loss of $2.4M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review RetinalGenix Technologies Inc..
Write a review
News about RetinalGenix Technologies Inc.
News & sentiment via Polygon.io
RetinalGenix Technologies Inc.: frequently asked questions
Is RetinalGenix Technologies Inc. an American company?
RetinalGenix Technologies Inc. is a US-based company headquartered in Petaluma, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is RetinalGenix Technologies Inc. headquartered?
RetinalGenix Technologies Inc. is headquartered in Petaluma, California, United States.
Is RetinalGenix Technologies Inc. publicly traded?
Yes — RetinalGenix Technologies Inc. is a publicly traded company. Its stock trades under the ticker symbol RTGN on the OTC.
What does RetinalGenix Technologies Inc. do?
RetinalGenix Technologies Inc. is an American Medical Devices company in the Health & Beauty sector.
